S

Sarepta Therapeutics
D

SRPT

106.280
USD
-2.01
(-1.86%)
مغلق
حجم التداول
25,845
الربح لكل سهم
12
العائد الربحي
-
P/E
69
حجم السوق
10,151,828,402
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    BIIB
    BIIB
    3.560
    (2.60%)
    140.630 USD
    B
    BLUE
    -2.93000
    (-41.68%)
    4.10000 USD
    C
    CRSP
    -2.620
    (-5.19%)
    47.840 USD
    E
    EDIT
    -0.14000
    (-6.80%)
    1.92000 USD
    GILD
    GILD
    -0.140
    (-0.13%)
    109.920 USD
    I
    IONS
    -0.365
    (-1.12%)
    32.310 USD
    REGN
    REGN
    4.37
    (0.63%)
    700.66 USD
    R
    RGLS
    0.05500
    (4.31%)
    1.33000 USD
    VRTX
    VRTX
    4.10
    (0.85%)
    484.53 USD
    المزيد
الأخبار
المقالات

العنوان: Sarepta Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of company's product candidates are at an early stage of development.